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Abstract
Objectives To determine the prevalence of female genital
mutilation (FGM) in women giving birth in 2008 in the
Netherlands.
Method A retrospective questionnaire study was con-
ducted. The study covered all 513 midwifery practices in
the Netherlands. The data were analysed with SPSS 17.0.
Results The response from midwifery practices was 93%
(n = 478). They retrospectively reported 470 circumcised
women in 2008 (0.32%). The expected prevalence in the
Netherlands based on the estimated prevalence of FGM in
the country of birth was 0.7%. It is likely that there was
underreporting in midwifery practices since midwives do
not always enquire about the subject and may not notice the
milder types of FGM. Midwives who checked their records
before answering our questionnaire reported a prevalence
of 0.8%.
Conclusion On the basis of this study, we can conclude
that FGM is a serious clinical problem in Europe for
migrant women from risk countries for FGM. These
women should receive extra attention from obstetricians
and midwives during childbirth, since almost half are
mutilated and FGM involves a risk of complications during
delivery for both women and children.
Keywords Female genital mutilation  Prevalence 
Midwifery practices  Country of birth  Migrants 
Delivery
Introduction
Demographic Health Surveys (DHS), implemented by
Macro International for USAID and Multiple Cluster
Indicator Surveys (MICS), implemented by national gov-
ernments with technical assistance from UNICEF or other
UN agencies are now carried out in many developing
countries. They provide reliable data on the prevalence of
FGM (WHO 2008). The original term used was ‘female
circumcision’. It was subsequently abandoned because of
the confusing reference to male circumcision. The term
‘female genital mutilation’ (FGM) was introduced to
emphasize the gravity and harm of the act and, more
recently, the UN agencies introduced the term ‘female
genital cutting’ as a less judgmental term for practicing
communities (WHO 2008). This article uses the expression
FGM for all of the above terms. On the basis of DHS and
D. G. Korfker (&)  M. E. B. Rijnders
TNO Innovation for Life, Leiden, The Netherlands
e-mail: dineke.korfker@tno.nl
R. Reis  S. E. Buitendijk
Leiden University Medical Center (LUMC),
Leiden, The Netherlands
R. Reis
Amsterdam Institute for Social Science Research (AISSR),
University of Amsterdam, Amsterdam, The Netherlands
S. Meijer-van Asperen
BovenIJ Hospital, Amsterdam, The Netherlands
L. Read
OLVG Hospital, Amsterdam, The Netherlands
L. Read
Midwifery Practice Bijlmermeer, Amsterdam, The Netherlands
M. Sanjuan
Midwifery Practice Vida, Amsterdam, The Netherlands
K. Herschderfer
Royal Tropical Institute, Amsterdam, The Netherlands
Int J Public Health (2012) 57:413–420
DOI 10.1007/s00038-012-0334-4
123
MICS studies, WHO estimates that between 100 and 140
million girls and women worldwide have been subjected to
FGM. An estimated 3 million girls are at risk of FGM
every year (Yoder et al. 2004).
In 1997, the WHO/UNICEF/UNFPA Joint Statement
listed four types of FGMs. Experience in the last decade
has identified some ambiguities in this classification.
Modifications were therefore introduced in 2008 to
accommodate concerns and shortcomings while maintain-
ing a four-category classification (Table 1).
The influx into Europe of refugees and asylum seekers
from countries where FGM is practised means that gov-
ernments and health care systems need to address the
phenomenon of FGM, as do health care providers. Fol-
lowing a period of doubt about which stand to take, the
medical professions throughout Western Europe have
uniformly condemned the practice of FGM. In many
countries, FGM is punishable under general criminal law.
Ten European countries (Austria, Belgium, Cyprus, Den-
mark, Italy, Norway, Portugal, Spain, Sweden and the UK)
have now introduced specific criminal provisions prohib-
iting the procedure (Powell et al. 2004; Leye 2008; Leye
and Sabbe 2009). The large majority of European countries
have included the principle of extraterritoriality in the
criminal provisions, making it possible to prosecute for
FGM even when it is perpetrated in African, Asian or
Middle Eastern countries (Leye and Sabbe 2009).
FGM prevalence in Europe
Until now, it has been assumed that the prevalence of FGM
in European immigrants is roughly the same as in the
countries of origin. This assumption is not based on solid
evidence since FGM prevalence in Europe has not often
been investigated in culturally sensitive studies involving
the target group itself. Leye (2008) summarises what she
calls ‘anecdotal’ evidence about the prevalence of FGM in
some European countries. Estimates for Belgium, Spain,
Sweden and the UK are based on census data and the
extrapolation of prevalence data in the countries of origin
(Powell et al. 2004; Leye 2008). In the UK the overall
approach was to identify countries where FGM is practiced
and from where there is significant migration to England
and Wales, to identify published data about the prevalence
of FGM in those countries and apply them to census and
birth registration data for England and Wales obtained
from the Office for National Statistics (Dorkenoo et al.
2007). Andro and Les Clingand (2007) made a low, middle
and high estimation for FGM in France based on the
prevalence in the country of origin and the age upon arrival
in France. Dubourg et al. (2011) applied data about prev-
alence of FGM from the most recently published DHS and
MICS to females living in Belgium who migrated from
countries where excision or infibulation are being prac-
tised, and to their daughters.
The prevalence of FGM in young girls in Europe is also
mainly based on assumptions. Investigation is rendered
even more difficult because of the clandestine atmosphere
surrounding the practice. Since FGM is considered a
criminal act in the Netherlands, reporting of the FGM
status of their daughters by mothers is difficult. As a result
in the Netherlands, FGM in young girls can only reliably be
verified by medical inspection and the ethical justification
for the examination has been questioned.
In 2005, the prevalence of FGM in young girls in the
Netherlands was estimated using questionnaires completed
by doctors and teachers. The result was a rough estimate of
50 girls undergoing FGM annually (Bijlsma-Schlosser and
van Eerdenburg-Keuning 2005). In Sweden, a group of
researchers from risk countries investigated the prevalence
of FGM in women of reproductive age. Being from the same
background they were able to survey women from risk
countries since they were trusted and they were able to
conduct examinations of genitalia in a smaller group.
Prevalence was 68% in the survey group (n = 254) and 62%
in the examination group (n = 39) (Kangoum et al. 2004).
To design effective prevention programmes, it is also
important to understand the risk of FGM for young girls
living in Europe. Several European countries recently
calculate the number of girls at risk for FGM, most recently
in Belgium (Dubourg et al. 2011). In this calculation, the
range in the age of risk is wider than the range generally
used in the country of origin. This is because it is known
that arranging FGM from Europe is often more difficult,
involving a long search for someone in the country of
residence who carries out FGM clandestinely or a trip to
the country of origin.
Table 1 WHO (2008) classification of types of female genital mutilation
Type I: Partial or total removal of the clitoris and/or the prepuce (clitoridectomy)
Type II: Partial or total removal of the clitoris and the labia minora, with or without excision of the labia majora (excision)
Type III: Narrowing of the vaginal orifice with creation of a covering seal by cutting and appositioning the labia minora and/or the labia majora,
with or without excision of the clitoris (infibulations)
Type IV: All other harmful procedures to the female genitalia for non-medical purposes, for example: pricking, piercing, incising, scraping and
cauterization
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Health consequences
FGM has consequences for the health of women and girls
(Obermeyer 2005; Elgaali et al. 2005; Tamaddon et al.
2006) and so it has introduced a new health problem to
Europe. In addition to the general health problems caused
by FGM, like urinary track infections and recurrent local
infections, FGM has obstetrical consequences, especially in
cases of infibulation (Vangen et al. 2002; Eke and Nkan-
ginieme 2006; Small et al. 2008; Carolan 2010; Boama and
Arulkumaran 2009). Small et al. compared pregnancy
outcomes for Somali-born women with those of women
born in receiving countries. They found that Somali-born
women were less likely to give birth preterm or to have
infants with low birth weight, but there was an excess of
caesarean sections, particularly in first births, and an excess
of stillbirths (Small et al. 2008). Establishing the magni-
tude of the problem will challenge doctors, midwives and
obstetricians to take preparations to support these women.
Several studies in Western countries have concluded that
changes in clinical practice are needed to incorporate
mutilated women’s perceptions and needs, and to enhance
sensitivity to cross-cultural practices (Chalmers and Hashi
2000; Vangen et al. 2002). Midwives and obstetricians
need proper training to make them competent to manage
women with FGM and they need an increased under-
standing of cultural backgrounds in order to provide quality
care for these women (Jäger et al. 2002; Vangen et al.
2004; Thierfelder et al. 2005; Zaidi et al. 2007; Lundberg
and Gerezgiher 2008; Leye et al. 2008).
It is important to elaborate an integrated European
agenda addressing research, training for professionals, and
community education (Powell et al. 2004).
The present study was the first to systematically study
the prevalence of observed FGM in women during preg-
nancy and childbirth at the national level in a European
country. This approach was adopted because it is only
during pregnancy and childbirth that women can be asked
functional questions about FGM and can be examined
without ethical restrictions.
Method
In this study, it was decided that investigating the preva-
lence of FGM by conducting a survey of the women would
not be feasible; it was expected that women from risk
countries living in the Netherlands would underreport FGM
due to the social taboo and the threat of legal proceedings.
Furthermore, we expected a low response rate because of
cultural and linguistic communication problems. Examin-
ing genitalia is the most accurate way of obtaining
information about the prevalence of FGM. Pregnancy and
childbirth provide a natural opportunity for this examina-
tion. Since 85% of pregnant women in the Netherlands are
cared for by midwives at some juncture during their ante-
natal, intrapartum and/or postpartum period, it was decided
to conduct a survey of all midwifery practices in the
Netherlands (n = 513) (Stichting Perinatale Registratie
Nederland 2008). In addition, a retrospective design was
adopted to surmount the time constraints as the Dutch
Government needed information about FGM prevalence as
soon as possible since they had promised the Dutch Par-
liament to provide this information. The limitation of
retrospective reporting based on memory was considered
an acceptable risk because the period between the year
midwives observed the FGM (2008) and the questionnaire
(February 2009) was limited.
In February 2009, all midwifery practices in the Nether-
lands received a letter explaining the background and reasons
for this study and a very short questionnaire with five
questions about prevalence, the type of FGM and questions
to check the validity of their assessment. It was expected that,
because of the heavy workload of midwives, a long ques-
tionnaire would negatively influence the response rate.
It was not possible to ask about the women’s country of
birth because this information is not routinely registered in
the national midwifery care registration system (LVR). To
calculate the prevalence of FGM, the midwives were asked
to report the total number of pregnant women coming
under their control in 2008. For the purpose of this retro-
spective study, the midwives were asked to distinguish
between two types of FGM: infibulation (type III) and any
other forms (types I, II and IV). In general, Dutch mid-
wives have relatively little experience with FGM, and so it
was not to be expected that they would be able to recognise
type IV or differentiate between types I and II, especially if
they were relying on memory.
Reminders were sent to non-responders after 4 weeks.
Non-responders residing in areas with a low response were
contacted by telephone. The data were analysed with SPSS
17.0. The Chi-square test was used to compare proportions,
and analysis of variance (ANOVA) to compare means
between groups. p values\0.05 were considered significant.
Results
The overall response rate from the 513 midwifery practices
was 93% (n = 478). Eventually, the analysis was based on
470 practices (92%) because eight questionnaire were not
fully completed. All regions in the Netherlands were
equally represented, including urban and rural areas. The
midwifery practices reported seeing 145,492 pregnant
women during the study period. Due to the very high
response rate, this was 79% of the total number of women
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(184,660) who gave birth in the Netherlands in 2008 (data
from Statistics Netherlands). Since 15% of pregnant
women in the Netherlands are cared for by obstetricians,
midwifery practices that did not reply represent 6% of the
deliveries in 2008. Almost 40% of the midwifery practices
reported seeing one or more mutilated women in 2008. A
total of 470 cases of FGM were reported: a prevalence rate
in all women delivered in the Netherlands in 2008 of
0.32% (95% CI 0.31–0.34%). In other words, 3 in 1,000 of
the women in this study population were reported as having
undergone FGM.
The midwifery practices reported seeing 188 (40%) in-
fibulations (type III FGM) and 237 (50%) other types of
FGM. They did not remember or did not know which FGM
type to report in 36 cases (8%) and 9 responders (2%)
failed to return this information.
During this study, we made a theoretical estimate of the
expected prevalence of FGM in the Netherlands using
national birth registration data for 2008. These records
include the country of origin, while the National Midwifery
Care Registry (LVR) does not. A rough calculation was
made of the number of women from the 15 highest-risk
countries (defined as prevalence of more than 40%), and
the actual prevalence of FGM in the country of origin. The
results of this exercise can be found in Table 2.
Using this method and assuming that FGM prevalence
in women giving birth in the Netherlands is comparable to
FGM prevalence in the countries of origin, FGM could be
expected in 1,341 women who gave birth in 2008. This
corresponds to a prevalence of 89% in women from risk
countries. Actual prevalence was calculated using data
from the national birth records and the results of the survey
of midwifery practices. According to these national birth
registration data, 1504 women from countries with a high
prevalence of FGM gave birth in 2008. Since midwives
reported on 79% (n = 145,492) of the pregnant population
in the Netherlands, it is assumed that they saw 1,188
(=79%) of the 1,504 women from risk countries who gave
birth in 2008. In the study, midwives reported 470 and not
the expected 1,188 cases of FGM, resulting in an estimated
prevalence rate of 40% in women from high prevalence
countries of origin who reside in the Netherlands. This is
far lower than the calculated expected prevalence of 89%.
The expected overall prevalence in the Netherlands
based on prevalence in the country of origin was 1,341 out
of 184,660 (total number of births). This is a prevalence
rate of 0.7%, which is more than twice the 0.32% reported
by the midwives.
Of the 183 midwifery practices who reported cases of
FGM, 70% had seen one or two women with FGM and 6%
had seen more than 8 women with FGM during the study
period. The distribution of FGM in the midwifery practices
can be found in Table 3.
The midwifery practices with the highest number of
reported FGM cases were mainly located in the larger cities
or close to refugee and centres for asylum seekers (ASC).
The prevalence of FGM was highest in the two largest
cities in the Netherlands: 4.6 per 1,000 women in
Amsterdam and 5.5 per 1,000 women in Rotterdam.
Table 2 Expected number of female genital mutilation in live births























Burkina Faso 4 72.5 3
Ivory Coast 41 41.7 17
Djibouti 3 93.1 3
Egypt 269 95.8 258
Eritrea 35 88.7 31
Ethiopia 177 74.3 132




Liberia 58 45 26
Mali 0 91.6 0
Mauretania 4 71.3 3
Sierra Leone 131 94 123
Somalia 592 97.9 578
Sudan 173 90 156
Chad 4 44.9 2
Total 1,504 89.2 1,341
a Source: data from Statistics Netherlands
b Source: WHO (2008)
Table 3 Number of female genital mutilation cases by number of
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Of the 183 midwifery practices who reported FGM for
2008, 124 (68%) answered that they were certain about the
number of cases they reported. A significant difference
(p \ 0.0001) was found in FGM prevalence between the
midwifery practices that were not certain about the number
of cases of FGM reported and those who were certain: 226
(48%) uncertain cases in 25,261 women (0.9%) compared to
244 (52%) certain cases in 42,637 (0.6%). It appears that
uncertainty about the number of women with FGM is
associated with an increase in the number of cases reported,
and this could indicate that the number is overestimated.
In the group practices who reported that they were
certain about the validity of their reporting, some checked
their records and others did not. A comparison of these two
groups showed up a significant difference (p = 0.001) in
the prevalence of FGM: in the group who checked records,
132 cases were reported in 16,270 women (0.8%), as
compared to 111 cases in 26,017 women (0.4%) in the
group that did not check their records. This indicates that
memory was indeed a serious problem. However, an
important reason for the lower prevalence in the group that
did not check the records is that practices with only one
case of FGM easily remembered the number, were certain
about the number (90% were certain) and had no reason to
check their records.
Discussion
Accurate data on the prevalence of FGM in Europe are
indispensable for monitoring and evaluating programmes
and activities. In general, it has been assumed that the
prevalence of FGM in immigrant women in Europe is
comparable to prevalence in their countries of origin.
However, several critical limitations of these prevalence
studies were also mentioned (Leye et al. 2006).
The study shows a lower prevalence of FGM in women
seen by midwifery practices in the Netherlands in 2008
compared to the prevalence data from women of repro-
ductive age in the countries of origin. The overall
prevalence in the Netherlands based on the prevalence in
the country of origin would be 0.7% and the prevalence
found in the Netherlands was 0.32%.
Lower prevalence is likely when the immigrants are not
a typical selection of the population in the country of ori-
gin. The prevalence in the country of origin as presented in
Table 2 does not take into consideration that FGM is
related to ethnic affiliation and not country of birth (De
Bruyn 2003). This might influence the prevalence in a
specific migrant population. For example, if all migrants
from Sudan in the Netherlands belong to the Christian sub-
group that does not practise FGM, the prevalence in the
Netherlands will be relatively low.
The migrant women may have a higher educational
level and/or socio-economic status and immigrant women
who grew up in their home country and those who grew up
in Europe would have different risks of having undergone
FGM. More in-depth research is required in this area.
Recent studies in Egypt confirm that there is less FGM
among daughters of highly educated and empowered
women in large cities. These women were 8 times more
likely not to plan FGM for their daughters than women
with lower educational levels and less empowerment (El-
Gibaly et al. 2002; Tag-Eldin et al. 2008; Afifi 2009). The
latest Demographic and Health Survey of Egypt and a
study in Upper Egypt indicate that FGM remains highly
prevalent in rural areas despite the law (El-Zanaty and Way
2009; Hassanin et al. 2008). If it turns out to be the case
that Egyptian immigrants in the Netherlands are predomi-
nantly from urban areas, the prevalence of FGM could be
lower. A qualitative study in Sweden of Ethiopian and
Eritrean men and women found that they firmly rejected all
forms of FGM and it was concluded that children from
these countries run little risk of FGM in Sweden (Johnsd-
otter et al. 2009). Again in Sweden, a questionnaire
answered by 2,702 health care providers yielded answers
supporting the hypothesis that this practice is not as
widespread among African immigrants in Sweden as in
their countries of origin. Although many migrant women in
Sweden express negative attitudes towards FGM, at the
same time there are attitudes in support of the practice
(Litorp et al. 2008). The study of Ahlberg et al. (2004)
making sense of eradication interventions and the persis-
tence of female circumcision within the Swedish context
was discussed by Johnsdotter and Essén (2005) who see
reasons to focus on processes of abandonment of the
practice instead of persistence. Morison et al. (2004) con-
cludes in a study among young Somalis in London that
Those who were living in Britain before they had reached
the usual age for circumcision were less likely to be cir-
cumcised (42%) than those who arrived after they had
reached that age (91%). A recent study in the Netherlands
of 66 women, mainly from the Horn of Africa, confirms
that FGM is waning. Parents stated that they did not want
FGM for their daughters (Vloeberghs et al. 2010).
Underreporting will also have contributed to the fact that
we did not find a prevalence of 0.7%. The main reason for
underreporting FGM is that the midwives did not recognise
all the forms of FGM, especially the milder forms, due to
lack of experience with the phenomenon and a lack of
training on the subject. Another possible reason for
underreporting FGM is that some of the reported infor-
mation came from memory. When midwives checked their
records they found a prevalence of 0.8%, which is similar
to the expected prevalence of 0.7%. In the group that did
not check their records, we found a prevalence of only
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0.4%, probably because practices with only one or two
cases easily remembered the occurrence and had no need to
check. More than half of the practices were certain about
the number and those practices had a prevalence of 0.6%,
which we consider to be close to actual prevalence.
Still another reason for the underreporting of FGM in
the study population is that midwives sometimes referred
women with FGM to an obstetrician without asking them
about FGM or conducting vaginal inspections. The referral
rate from midwives to obstetricians during pregnancy is
30% (Stichting Perinatale Registratie Nederland 2008).
Midwives in the Netherlands do not routinely inspect
women’s vulvas prior to delivery, although guidelines do
require them to do so.
A study carried out by midwifery students in the Neth-
erlands in 2005–2006 also arrived at a prevalence rate of
0.3%. The same study showed that 36% of midwifery
practices did not ask their clients about FGM and that, in the
cases where the women were asked and had stated that they
had been mutilated, only 60% of the midwives subsequently
inspected the vulva during antenatal care. Midwives notice
FGM at the moment of the delivery. Since the completion of
this study, the Royal Dutch Midwifery Organisation has
published a statement recommending that midwives should
inquire about FGM early in the pregnancy.
To obtain a complete picture of the prevalence of FGM
in the Netherlands, data should be recorded in the national
registration system where gynaecologists also record their
data. However, FGM will only be recorded in a newly
developed dataset that has yet to be put into practice.
The study also shows that, of all the reported cases of
FGM, 40% were classified as infibulations and 50% as
other types of FGM. This corresponds to the 44% for in-
fibulation found in a Swedish study (Kangoum et al. 2004).
In Melbourne, 78% of the women identified as having had
FGM were found to have undergone infibulation (Knight
et al. 1999). In the Netherlands, Vloeberghs et al. (2010)
recently found a rate of 53% for self-reported infibulation.
These rates do not correspond to the global percentage
stated by the World Health Organisation of 15% (WHO,
2008). In another Scandinavian study, 17% were infibu-
lated and 83% had other types of FGM (Elgaali et al.
2005). In Melbourne, the fluctuations could be explained
by the differences in the FGM culture in the countries of
origin. This also applies to our research population.
According to the National Registry the group of immigrant
women from countries where infibulation is more com-
monly practiced, such as Sudan and Somalia, represents
50% of the women from risk countries delivered in the
Netherlands. It is also possible that general underreporting
of FGM means that the underreported group includes a
higher proportion of FGM types I, II and IV because these
types are difficult to recognise.
Midwives seem to miss the milder forms of FGM and do
not know how to manage delivery in mutilated women was
concluded in the study of the midwifery students in
2005–2006. Broad schooling about the medical, social and
cultural components of FGM is therefore needed. Scar
tissue from infibulation and from milder forms can lead to
serious complications during delivery. The techniques of
episiotomy and suturing for women with FGM should be
known to midwives and obstetricians.
Conclusion
Midwives proved to be a valuable source of data about the
prevalence of FGM in the Netherlands. The extremely high
response rate gives an indication of the commitment of
midwives in the Netherlands to addressing the problem of
FGM.
The prevalence rate of 0.32% in women receiving
midwifery care in the Netherlands appears to be lower than
the expected prevalence of 0.7% based on prevalence data
in their countries of origin. However, midwifery practices
that checked their records found a prevalence of 0.8%,
which was even higher than the expected 0.7% based on
the prevalence in the home countries. We assume under-
reporting due to the difficulties in recognising FGM, not
asking women from risk countries about FGM and not
always checking women’s vulvas before referral to
gynaecologists. The retrospective character of the study
may also have contributed to underreporting. Notwith-
standing the underreporting we conclude that the
prevalence of FGM in the Netherlands is slightly lower
than in the countries of origin because 52% of the mid-
wives that were sure about the reported numbers found a
prevalence of 0.6%.
The study shows that FGM is a health problem in Eur-
ope and that it needs to be addressed as a serious clinical
problem. Assuming that 0.3–0.7% of all pregnant women
are mutilated, the magnitude of the problem is comparable
with that of extra-uterine pregnancy (which has a preva-
lence of 1%) and more common than a rupture of the uterus
(5.9 per 100,000 births).
Recommendations
FGM is relatively common, at least compared to other
issues resulting in maternal morbidity. It is important,
therefore, to ensure that midwives and obstetricians are
knowledgeable and skilled in recognising the various types
of FGM and that they are capable of approaching the
subject in an appropriate and sensitive manner. To provide
culturally sensitive and migrant friendly maternity care, an
extensive training effort is needed for medical students and
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trained health workers. In addition, because circumcised
women are likely to circumcise their daughters too, it is
important for reproductive health personnel to learn to raise
FGM as an issue in order to prevent FGM in the girls they
have delivered.
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